Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity
(Excel Data Sheet: $1,500)
The report cover may be different from the image shown.
- The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order.
- To learn more about the report, please Download Free Sample Pages and Download Excel Datasheet Sample. The report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
- PleaseContact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.
Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.
Based on Service, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Europe Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Europe Market by Service 44
3.1 Market Overview by Service 44
3.2 CRO for Pre-clinical Development 46
3.3 CRO for Phase I Trials 47
3.4 CRO for Phase II Trials 48
3.5 CRO for Phase III Trials 49
3.6 CRO for Phase IV Trials 50
3.7 Laboratory Services 51
3.8 Consulting Services 52
3.9 Data Management Services 53
4 Segmentation of Europe Market by Therapeutic Application 54
4.1 Market Overview by Therapeutic Application 54
4.2 Infectious Diseases 56
4.3 Oncology 57
4.4 Metabolic Disorders 58
4.5 Cardiovascular Disorders 59
4.6 Central Nervous System 60
4.7 Respiratory Disorders 61
4.8 Gastrointestinal Disorders 62
4.9 Other Therapeutic Applications 63
5 Segmentation of Europe Market by End User 64
5.1 Market Overview by End User 64
5.2 Pharmaceutical & Biopharmaceutical Companies 66
5.3 Medical Device Companies 67
5.4 Academic Institutes 68
6 European Market 2019-2030 by Country 69
6.1 Overview of European Market 69
6.2 Germany 72
6.3 UK 74
6.4 France 77
6.5 Spain 79
6.6 Italy 81
6.7 Russia 83
6.8 Rest of European Market 85
7 Competitive Landscape 87
7.1 Overview of Key Vendors 87
7.2 New Product Launch, Partnership, Investment, and M&A 91
7.3 Company Profiles 92
Charles River Laboratories 92
CMIC Co. Ltd 94
Covance Inc. 96
Hangzhou Tigermed Consulting Co., Ltd. 100
ICON Plc 103
IQVIA Holdings Inc. 106
LSK Global Pharma Service Co., Ltd. 110
Novotech Pty Ltd 112
PAREXEL International Corporation 114
Pharmaceutical Product Development LLC (PPD) 118
PRA Health Sciences Inc. 120
Quanticate Ltd 122
Samsung Bioepis Co., Ltd. 124
SGS SA (SGS Life Sciences) 126
Syneos Health Inc. 129
WuXi AppTec Inc. 132
8 Investing in Europe Market: Risk Assessment and Management 134
8.1 Risk Evaluation of Europe Market 134
8.2 Critical Success Factors (CSFs) 137
Related Reports and Products 140
List of Tables:
Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market 36
Table 7. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn 44
Table 8. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 54
Table 9. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn 64
Table 10. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 71
Table 11. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 73
Table 12. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 73
Table 13. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 73
Table 14. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76
Table 15. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76
Table 16. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76
Table 17. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 78
Table 18. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 78
Table 19. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 78
Table 20. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 80
Table 21. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 80
Table 22. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 80
Table 23. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 82
Table 24. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 82
Table 25. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 82
Table 26. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 84
Table 27. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 84
Table 28. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 84
Table 29. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 86
Table 30. Breakdown of World Market by Key Vendor, 2020, % 89
Table 31. Charles River Laboratories: Company Snapshot 92
Table 32. Charles River Laboratories: Product Portfolio 93
Table 33. CMIC Co. Ltd.: Company Snapshot 94
Table 34. CMIC Co. Ltd.: Business Segmentation 95
Table 35. CMIC Co. Ltd.: Revenue by Region, 2018, % 95
Table 36. Covance Inc.: Company Snapshot 96
Table 37. Covance Inc.: Product Portfolio 97
Table 38. Covance Inc.: Revenue by Region, 2020, % 98
Table 39. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot 100
Table 40. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation 101
Table 41. ICON Plc: Company Snapshot 103
Table 42. ICON Plc: Business Segmentation 103
Table 43. ICON Plc: Product Portfolio 104
Table 44. ICON Plc: Revenue by Region, 2020, % 104
Table 45. IQVIA Holdings Inc.: Company Snapshot 106
Table 46. IQVIA Holdings Inc.: Business Segmentation 107
Table 47. IQVIA Holdings Inc.: Revenue by Region, 2020, % 107
Table 48. IQVIA Holdings Inc.: Product Portfolio 108
Table 49. LSK Global Pharma Service Co., Ltd.: Company Snapshot 110
Table 50. Novotech Pty Ltd: Company Snapshot 112
Table 51. PAREXEL International Corporation: Company Snapshot 114
Table 52. PAREXEL International Corporation: Business Segmentation 115
Table 53. PAREXEL International Corporation: Revenue by Region, 2018, % 115
Table 54. PAREXEL International Corporation: Product Portfolio 116
Table 55. Pharmaceutical Product Development LLC (PPD): Company Snapshot 118
Table 56. PRA Health Sciences Inc.: Company Snapshot 120
Table 57. PRA Health Sciences Inc.: Business Segmentation 121
Table 58. PRA Health Sciences Inc.: Revenue by Region, 2018, % 121
Table 59. Quanticate Ltd: Company Snapshot 122
Table 60. Samsung Bioepis Co., Ltd.: Company Snapshot 124
Table 61. SGS SA (SGS Life Sciences): Company Snapshot 126
Table 62. SGS SA (SGS Life Sciences): Business Segmentation 127
Table 63. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 127
Table 64. Syneos Health Inc.: Company Snapshot 129
Table 65. Syneos Health Inc.: Business Segmentation 130
Table 66. Syneos Health Inc.: Revenue by Region, 2018, % 130
Table 67. WuXi AppTec Inc.: Company Snapshot 132
Table 68. Risk Evaluation for Investing in Europe Market, 2021-2030 135
Table 69. Critical Success Factors and Key Takeaways 138
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 17
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market 25
Figure 8. Leading Causes of Death in the World, 2019-2020, million 30
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 11. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market 33
Figure 12. Investment Opportunity Analysis 37
Figure 13. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market 40
Figure 14. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 45
Figure 15. Europe Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 45
Figure 16. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 46
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 47
Figure 18. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 48
Figure 19. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 49
Figure 20. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 50
Figure 21. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 51
Figure 22. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 52
Figure 23. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 53
Figure 24. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 55
Figure 25. Europe Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 55
Figure 26. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 56
Figure 27. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 57
Figure 28. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 58
Figure 29. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 59
Figure 30. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 60
Figure 31. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 61
Figure 32. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 62
Figure 33. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 63
Figure 34. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 65
Figure 35. Europe Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 65
Figure 36. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 66
Figure 37. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 67
Figure 38. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 68
Figure 39. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 70
Figure 40. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 71
Figure 41. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 72
Figure 42. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 74
Figure 43. Pharmaceutical CRO Market in France, 2019-2030, $ bn 77
Figure 44. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 79
Figure 45. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 81
Figure 46. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 83
Figure 47. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 85
Figure 48. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period 87